Bhavana Bhatnagar

Bhavana Bhatnagar conducts clinical research on blood cancers, including acute myeloid leukemia, acute lymphoblastic leukemia, chronic myeloid leukemia, myeloproliferative neoplasms, and multiple myeloma. Much of the work involves multi-center clinical trials testing new drug combinations and treatment strategies, as well as studies on genomic factors and disparities (such as rurality and socioeconomic status) that affect patient outcomes. This research is typically conducted as part of large collaborative groups such as ECOG-ACRIN, involving many co-authors across institutions.

Publication output has fluctuated over the past decade with a notable surge in 2025, following periods of both high (2020-2021, 2023) and low (2022, 2024) activity, suggesting an overall growing but variable output.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026